Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Xtant Medical Holdings, Inc. XTNT

Healthcare  —  Medical Devices
0.38 0.00 0.00% as of 25 Sep
Market cap
$52.9M
P/E
0.0×
Revenue Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Xtant Medical Holdings, Inc. (XTNT) Business Profile

Updated before January 2025

Company Overview

Xtant Medical Holdings, Inc. (XTNT) is a leading global medical technology company specializing in the design, development, and commercialization of regenerative medicine products and medical devices. Founded in 2006 and headquartered in Belgrade, Montana, Xtant Medical has established itself as a key player in the healthcare industry, particularly in the fields of orthopedics, neurosurgery, and spinal surgery. The company was initially formed through the merger of Bacterin International and X-Spine Systems, combining expertise in biologics and hardware solutions.

Xtant Medical is led by a team of experienced executives and medical professionals. As of the latest update, the company’s leadership includes Sean Browne as President and Chief Executive Officer, who brings extensive experience in the medical device and healthcare sectors. The leadership team is committed to advancing innovation and delivering high-quality solutions to improve patient outcomes.

Core Business Segments

Xtant Medical operates through two primary business segments: biologics and medical devices. These segments are designed to address the needs of healthcare providers and patients in the areas of spinal surgery, orthopedics, and regenerative medicine.

Biologics

Xtant Medical’s biologics portfolio includes a wide range of regenerative medicine products that are used to promote healing and tissue regeneration. These products are primarily derived from human tissue and are processed to ensure safety and efficacy. Key products in this category include:

  • OsteoSponge®: A demineralized bone matrix (DBM) product designed to support bone growth and healing.
  • OsteoSelect® DBM Putty: A moldable bone graft substitute that provides excellent handling characteristics for surgeons.
  • OsteoWrap®: A flexible bone graft solution used in spinal and orthopedic procedures.
  • 3Demin®: A line of demineralized cancellous bone products that promote osteogenesis.

Medical Devices

The medical devices segment focuses on hardware solutions for spinal surgery and other orthopedic applications. These devices are designed to provide stability, alignment, and support during surgical procedures. Key products in this category include:

  • Axle® Interspinous Fusion System: A minimally invasive device for spinal fusion procedures.
  • Silex® Sacroiliac Joint Fusion System: A system designed to stabilize and fuse the sacroiliac joint.
  • Fortex® Pedicle Screw System: A comprehensive system for spinal fixation.
  • Xpress® Minimally Invasive Surgery (MIS) System: A suite of tools and implants for minimally invasive spinal surgery.

Business Model

Xtant Medical’s business model is centered around the integration of biologics and medical devices to provide comprehensive solutions for healthcare providers. The company generates revenue through the sale of its products to hospitals, surgical centers, and healthcare professionals. Xtant Medical also collaborates with tissue banks and other partners to ensure a steady supply of high-quality biologic materials.

The company’s approach emphasizes innovation, quality, and customer service. By combining advanced technology with rigorous quality control processes, Xtant Medical aims to deliver products that meet the highest standards of safety and efficacy. Additionally, the company invests in research and development to expand its product portfolio and address emerging needs in the healthcare market.

Strategic Direction

Xtant Medical is focused on driving growth through innovation, market expansion, and operational excellence. Key strategic initiatives include:

  • Product Development: The company is investing in the development of new biologics and medical devices to address unmet clinical needs.
  • Market Expansion: Xtant Medical aims to expand its presence in international markets, particularly in regions with growing demand for advanced medical technologies.
  • Sustainability Goals: The company is committed to sustainable practices, including ethical sourcing of biologic materials and reducing its environmental footprint.
  • Partnerships and Collaborations: Xtant Medical seeks to strengthen its relationships with healthcare providers, distributors, and research institutions to enhance its market position.

Competitive Landscape

Xtant Medical operates in a highly competitive market, facing competition from both large multinational corporations and smaller specialized companies. Key competitors include:

  • Medtronic: A global leader in medical technology, offering a wide range of spinal and orthopedic products.
  • Stryker Corporation: Known for its innovative medical devices and biologics.
  • Zimmer Biomet: A major player in the orthopedic and spinal surgery markets.
  • NuVasive, Inc.: Specializes in minimally invasive spinal surgery solutions.
  • Orthofix Medical Inc.: Focuses on regenerative medicine and spinal implants.

Despite the competitive landscape, Xtant Medical differentiates itself through its integrated approach, combining biologics and medical devices to provide comprehensive solutions.

Risk Factors

Xtant Medical faces several risks that could impact its business operations and financial performance. Key risk factors include:

  • Market Dependence: The company relies heavily on the success of its biologics and medical devices. Any decline in demand for these products could adversely affect revenue.
  • Regulatory Challenges: The medical device and biologics industries are subject to stringent regulatory requirements. Non-compliance could result in product recalls or delays in product approvals.
  • Supply Chain Disruptions: Dependence on third-party suppliers for raw materials and biologic tissues poses a risk of supply chain disruptions.
  • Competition: Intense competition from larger, well-established companies could limit Xtant Medical’s market share.
  • Economic Conditions: Economic downturns or changes in healthcare reimbursement policies could impact the company’s financial performance.

Recent Developments

Xtant Medical has recently introduced several new products and initiatives to strengthen its market position. Notable developments include:

  • Product Launches: The company has expanded its biologics portfolio with new offerings designed to enhance bone healing and regeneration.
  • Strategic Partnerships: Xtant Medical has entered into collaborations with leading healthcare providers to expand its distribution network.
  • Operational Improvements: The company has implemented cost-saving measures and process improvements to enhance operational efficiency.
  • Global Developments: The COVID-19 pandemic highlighted the importance of resilient supply chains and accelerated the adoption of telemedicine and minimally invasive procedures, areas where Xtant Medical is well-positioned.

Investment Considerations

Investors considering Xtant Medical should weigh the following strengths and risks:

Strengths

  • Innovative Product Portfolio: A diverse range of biologics and medical devices.
  • Market Growth: Strong demand for regenerative medicine and spinal surgery solutions.
  • Experienced Leadership: A management team with deep industry expertise.
  • Strategic Focus: Commitment to innovation and market expansion.

Risks

  • Regulatory and Compliance Risks: Potential challenges in meeting regulatory requirements.
  • Market Competition: Intense competition from larger players.
  • Economic Sensitivity: Vulnerability to changes in healthcare spending and reimbursement policies.

Conclusion

Xtant Medical Holdings, Inc. is a dynamic player in the medical technology industry, offering innovative solutions in biologics and medical devices. With a strong focus on innovation, quality, and customer service, the company is well-positioned to capitalize on growth opportunities in the healthcare market. However, investors should carefully consider the risks associated with regulatory compliance, market competition, and economic conditions. Overall, Xtant Medical’s integrated approach and commitment to advancing patient care make it a compelling choice for healthcare providers and investors alike.